Atlas Trials

TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Clinical trial NCT06561763 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06561763
Sponsor
Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
High Risk Locally Advanced Nasopharyngeal Carcinoma
Start date
2024-08-20
Primary completion
2028-08-20
Enrollment
416

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.